Search Result "Familial Hypercholesterolaemia (FH)"
Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including Registries
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3605-3615
Author(s): Matilda Florentin,Michael S. Kostapanos,Moses S. Elisaf,Evangelos N. Liberopoulos
New Horizons in the Pathogenesis, Pathophysiology and Treatment of Familial Hypercholesterolaemia
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3599-3604
Author(s): Margus Viigimaa,Silver Heinsar,Dragan Lovic,Alexandra Katsimardou,Alexia Piperidou,Davit Duishvili
Familial Hypercholesterolaemia in Children and Adolescents: Current and Future Perspectives
Journal: Current Pediatric Reviews
Volume: 19 Issue: 3 Year: 2023 Page: 234-241
Author(s): Pier Paolo Bassareo
Should we Consider Lipoprotein (a) in Cardiovascular Disease Risk Assessment in Patients with Familial Hypercholesterolaemia?
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3665-3671
Author(s): Panagiotis Anagnostis,Pavlos Siolos,Dimitrios Krikidis,Dimitrios G. Goulis,John C. Stevenson
The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results
Journal: Current Vascular Pharmacology
Volume: 18 Issue: 1 Year: 2020 Page: 57-64
Author(s): Khalid Al-Rasadi,Khalid F Alhabib,Faisal Al-Allaf,Khalid Al-Waili,Ibrahim Al-Zakwani,Ahmad AlSarraf,Wael Almahmeed,Nasreen AlSayed,Mohammad Alghamdi,Mohammed A Batais,Turky H Almigbal,Fahad Alnouri,Abdulhalim Kinsara,Ashraf Hammouda,Zuhier Awan,Heba Kary,Omer A Elamin,Fahad Zadjali,Mohammed Al-Jarallah,Abdullah Shehab,Hani Sabbour,Haitham Amin,Hani Altaradi
Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
Journal: Current Vascular Pharmacology
Volume: 13 Issue: 6 Year: 2015 Page: 759-770
Author(s): Abdullah Al-Ashwal, Fahad Alnouri, Hani Sabbour, Abdulraof Al-Mahfouz, Nasreen Al-Sayed, Maryam Razzaghy-Azar, Faisal Al-Allaf, Khalid Al-Waili, Yajnavalka Banerjee, Jacques Genest, Raul D. Santos, Khalid Al-Rasadi
Gene Therapy for Familial Hypercholesterolemia
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2575-2591
Author(s): Eline Van Craeyveld, Frank Jacobs, Stephanie C. Gordts, Bart De Geest
Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial Hypercholesterolemia
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3647-3653
Author(s): Vasilios Papademetriou,Konstantinos Stavropoulos,Christodoulos Papadopoulos,Konstantinos Koutsampasopoulos,Kiriakos Dimitriadis,Kostas Tsioufis
Familial Hypercholesterolemia: Etiology, Diagnosis and New Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6220-6229
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold
Lipoprotein Apheresis and PCSK9-Inhibitors. Impact on Atherogenic Lipoproteins and Anti-Inflammatory Mediators in Familial Hypercholesterolaemia
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3634-3637
Author(s): Claudia Stefanutti,Maria Grazia Zenti